PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Gustave Roussy, Villejuif, France. thomas.hueso@aphp.fr.\', \'Paris-Saclay University, Paris, France. thomas.hueso@aphp.fr.\', \'Infectious Diseases Department, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.\', \'Sorbonne Université, Inserm, Institut Pierre Louis d\'Épidémiologie et de Santé Publique (IPLESP), Paris, France.\', \'Department of Hematology, Hôpital André Mignot, Le Chesnay, France.\', \'Etablissement Français du Sang, La Plaine Saint-Denis, France.\', \'Institut Mondor de Recherche Biomédicale, Unité 955, Equipe 2: Transfusion et Maladies du Globule Rouge, Inserm, Etablissement Français du Sang, Université Paris-Est Créteil, Créteil, France.\', \'UMR 1098 RIGHT Inserm Université de Franche-Comté, Etablissement Français du Sang, Besançon, France.\', \'Université de Versailles, Saint Quentin en Yvelines/Université Paris-Saclay, Inserm, Equipe \'Exposome et Hérédité,\' CESP, Villejuif, France.\', \'Department of Hematology, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.\', \'Department of Hematology, CHU de Montpellier, Montpellier, France.\', \'Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, Imagine Institute, Paris, France.\', \'Infectious Diseases Department, CHU de Saint-Etienne, Saint-Priest-en-Jarez, France.\', \'Pneumology Department, CHU Lyon Sud, Hospices Civils de Lyon, Lyon, France.\', \'Department of Public Health, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint Antoine, Paris, France.\', \'Infectious Diseases Department, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France. karine.lacombe2@aphp.fr.\', \'Sorbonne Université, Inserm, Institut Pierre Louis d\'Épidémiologie et de Santé Publique (IPLESP), Paris, France. karine.lacombe2@aphp.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41375-022-01511-6
?:doi
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 35105946
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
is ?:relation_isRelatedTo_publication of
?:title
  • Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35105946>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35105946>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all